Gene Symbol | Gene ID | Gene Info |
---|---|---|
WT1
|
ENSG00000184937.8 | WT1 transcription factor |
MTF1
|
ENSG00000188786.9 | metal regulatory transcription factor 1 |
ZBTB7B
|
ENSG00000160685.9 | zinc finger and BTB domain containing 7B |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_38325568_38325823 | MTF1 | 403 | 0.573485 | 0.85 | 3.9e-03 | Click! |
chr1_38323797_38323983 | MTF1 | 1402 | 0.243433 | 0.67 | 4.9e-02 | Click! |
chr1_38324382_38324684 | MTF1 | 759 | 0.442350 | 0.59 | 9.5e-02 | Click! |
chr1_38318125_38318276 | MTF1 | 7092 | 0.100896 | 0.58 | 1.0e-01 | Click! |
chr1_38321147_38321298 | MTF1 | 4070 | 0.116467 | 0.55 | 1.2e-01 | Click! |
chr11_32354994_32355184 | WT1 | 67072 | 0.122515 | 0.94 | 2.1e-04 | Click! |
chr11_32452547_32452698 | WT1 | 263 | 0.932917 | 0.91 | 5.9e-04 | Click! |
chr11_32455817_32456007 | WT1 | 979 | 0.454187 | 0.85 | 3.4e-03 | Click! |
chr11_32456038_32456300 | WT1 | 722 | 0.511842 | 0.84 | 4.5e-03 | Click! |
chr11_32456588_32456739 | WT1 | 228 | 0.687356 | 0.83 | 6.0e-03 | Click! |
chr1_154980224_154980415 | ZBTB7B | 5024 | 0.078323 | 0.90 | 1.0e-03 | Click! |
chr1_154989037_154989850 | ZBTB7B | 2519 | 0.110676 | 0.88 | 1.7e-03 | Click! |
chr1_154973371_154973622 | ZBTB7B | 1631 | 0.160789 | 0.88 | 1.7e-03 | Click! |
chr1_154983358_154983509 | ZBTB7B | 3491 | 0.090461 | 0.88 | 1.8e-03 | Click! |
chr1_154982930_154983297 | ZBTB7B | 3811 | 0.086812 | 0.87 | 2.2e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_72984009_72984428 | 1.78 |
CDR2L |
cerebellar degeneration-related protein 2-like |
491 |
0.63 |
chr7_19156075_19156556 | 1.43 |
TWIST1 |
twist family bHLH transcription factor 1 |
980 |
0.47 |
chr17_1082802_1083000 | 1.34 |
ABR |
active BCR-related |
177 |
0.94 |
chr10_31609488_31609880 | 1.29 |
ENSG00000237036 |
. |
308 |
0.56 |
chr17_8025338_8025489 | 1.22 |
HES7 |
hes family bHLH transcription factor 7 |
1989 |
0.15 |
chr7_151107012_151107163 | 1.20 |
WDR86 |
WD repeat domain 86 |
19 |
0.93 |
chr14_61189693_61189844 | 1.17 |
SIX4 |
SIX homeobox 4 |
1084 |
0.55 |
chr11_125496038_125496275 | 1.16 |
CHEK1 |
checkpoint kinase 1 |
32 |
0.97 |
chr2_111880585_111880736 | 1.16 |
BCL2L11 |
BCL2-like 11 (apoptosis facilitator) |
413 |
0.88 |
chr1_27561128_27561279 | 1.09 |
WDTC1 |
WD and tetratricopeptide repeats 1 |
44 |
0.84 |
chr9_116638915_116639161 | 1.05 |
ZNF618 |
zinc finger protein 618 |
408 |
0.9 |
chr17_48278292_48278683 | 1.04 |
COL1A1 |
collagen, type I, alpha 1 |
506 |
0.68 |
chr8_131370141_131370292 | 1.03 |
ASAP1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 |
17033 |
0.29 |
chr7_1706254_1706638 | 1.02 |
ELFN1 |
extracellular leucine-rich repeat and fibronectin type III domain containing 1 |
21309 |
0.17 |
chr19_3366959_3367260 | 1.02 |
NFIC |
nuclear factor I/C (CCAAT-binding transcription factor) |
525 |
0.78 |
chr1_31214307_31214682 | 1.01 |
ENSG00000264773 |
. |
2415 |
0.24 |
chr8_30242153_30242439 | 0.99 |
RBPMS-AS1 |
RBPMS antisense RNA 1 |
40 |
0.77 |
chr15_70388524_70388821 | 0.97 |
TLE3 |
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
31 |
0.98 |
chr21_45577023_45577427 | 0.97 |
AP001055.1 |
|
16355 |
0.13 |
chr5_139028860_139029144 | 0.96 |
CXXC5 |
CXXC finger protein 5 |
484 |
0.83 |
chr12_54378978_54379226 | 0.96 |
HOXC10 |
homeobox C10 |
132 |
0.52 |
chr11_67141229_67141380 | 0.96 |
CLCF1 |
cardiotrophin-like cytokine factor 1 |
96 |
0.92 |
chr7_17338891_17339212 | 0.96 |
AC003075.4 |
|
70 |
0.94 |
chr16_727350_727692 | 0.95 |
RHBDL1 |
rhomboid, veinlet-like 1 (Drosophila) |
1446 |
0.13 |
chr17_48277708_48277975 | 0.95 |
COL1A1 |
collagen, type I, alpha 1 |
289 |
0.84 |
chr2_145275512_145275663 | 0.95 |
ZEB2-AS1 |
ZEB2 antisense RNA 1 |
77 |
0.56 |
chr2_27071961_27072112 | 0.95 |
DPYSL5 |
dihydropyrimidinase-like 5 |
660 |
0.72 |
chr9_139924977_139925128 | 0.95 |
ABCA2 |
ATP-binding cassette, sub-family A (ABC1), member 2 |
2312 |
0.09 |
chr19_52193071_52193310 | 0.94 |
ENSG00000207550 |
. |
2675 |
0.13 |
chr6_17281167_17281463 | 0.94 |
RBM24 |
RNA binding motif protein 24 |
262 |
0.95 |
chr5_95067499_95067689 | 0.94 |
CTD-2154I11.2 |
|
397 |
0.66 |
chr4_169753476_169753760 | 0.94 |
PALLD |
palladin, cytoskeletal associated protein |
426 |
0.51 |
chr16_84769489_84769763 | 0.92 |
USP10 |
ubiquitin specific peptidase 10 |
32245 |
0.17 |
chr8_81490427_81490652 | 0.91 |
ENSG00000223327 |
. |
7469 |
0.23 |
chr10_126107594_126107745 | 0.91 |
OAT |
ornithine aminotransferase |
124 |
0.96 |
chr1_186276454_186276605 | 0.90 |
ENSG00000202025 |
. |
4531 |
0.21 |
chr18_42260671_42260822 | 0.90 |
SETBP1 |
SET binding protein 1 |
117 |
0.98 |
chr1_167424277_167424611 | 0.90 |
RP11-104L21.2 |
|
3454 |
0.27 |
chr17_41173800_41174114 | 0.90 |
VAT1 |
vesicle amine transport 1 |
416 |
0.67 |
chr4_41883773_41883924 | 0.89 |
TMEM33 |
transmembrane protein 33 |
53289 |
0.14 |
chr2_85360155_85360383 | 0.89 |
TCF7L1 |
transcription factor 7-like 1 (T-cell specific, HMG-box) |
264 |
0.93 |
chr8_144655209_144655539 | 0.87 |
MROH6 |
maestro heat-like repeat family member 6 |
233 |
0.51 |
chr15_73344221_73344400 | 0.87 |
NEO1 |
neogenin 1 |
259 |
0.96 |
chr4_779522_779673 | 0.87 |
RP11-440L14.1 |
|
3960 |
0.15 |
chr1_94374970_94375121 | 0.86 |
GCLM |
glutamate-cysteine ligase, modifier subunit |
79 |
0.97 |
chr6_41395432_41395618 | 0.86 |
ENSG00000238867 |
. |
72338 |
0.08 |
chr18_60383377_60383667 | 0.85 |
PHLPP1 |
PH domain and leucine rich repeat protein phosphatase 1 |
839 |
0.65 |
chr1_78354156_78354308 | 0.85 |
NEXN |
nexilin (F actin binding protein) |
32 |
0.95 |
chr9_134466441_134466779 | 0.85 |
RAPGEF1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
30615 |
0.15 |
chr1_53386842_53387121 | 0.85 |
ECHDC2 |
enoyl CoA hydratase domain containing 2 |
395 |
0.76 |
chr11_45101428_45101680 | 0.85 |
PRDM11 |
PR domain containing 11 |
14010 |
0.27 |
chr10_71390210_71390493 | 0.84 |
C10orf35 |
chromosome 10 open reading frame 35 |
51 |
0.98 |
chr14_67708458_67708609 | 0.83 |
MPP5 |
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5) |
189 |
0.95 |
chr22_38071514_38071665 | 0.83 |
LGALS1 |
lectin, galactoside-binding, soluble, 1 |
26 |
0.95 |
chr15_81071526_81071677 | 0.83 |
KIAA1199 |
KIAA1199 |
83 |
0.98 |
chr9_124131865_124132016 | 0.82 |
STOM |
stomatin |
543 |
0.73 |
chr4_85886857_85887120 | 0.82 |
WDFY3 |
WD repeat and FYVE domain containing 3 |
515 |
0.87 |
chr3_185826394_185826545 | 0.82 |
ETV5 |
ets variant 5 |
5 |
0.98 |
chr5_14144289_14144440 | 0.82 |
TRIO |
trio Rho guanine nucleotide exchange factor |
535 |
0.88 |
chr3_50540388_50540630 | 0.81 |
CACNA2D2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
345 |
0.87 |
chr9_130966352_130966616 | 0.81 |
CIZ1 |
CDKN1A interacting zinc finger protein 1 |
178 |
0.83 |
chr11_1567764_1567915 | 0.81 |
DUSP8 |
dual specificity phosphatase 8 |
19327 |
0.12 |
chr3_149375939_149376119 | 0.80 |
WWTR1-AS1 |
WWTR1 antisense RNA 1 |
32 |
0.63 |
chr17_43096466_43096635 | 0.80 |
DCAKD |
dephospho-CoA kinase domain containing |
15959 |
0.12 |
chr19_2041628_2041930 | 0.80 |
MKNK2 |
MAP kinase interacting serine/threonine kinase 2 |
302 |
0.81 |
chr18_22930641_22930889 | 0.80 |
ZNF521 |
zinc finger protein 521 |
392 |
0.91 |
chr16_4744450_4744739 | 0.80 |
NUDT16L1 |
nudix (nucleoside diphosphate linked moiety X)-type motif 16-like 1 |
832 |
0.49 |
chr9_136149691_136149842 | 0.80 |
ENSG00000201843 |
. |
28187 |
0.09 |
chr9_114361618_114361849 | 0.80 |
PTGR1 |
prostaglandin reductase 1 |
46 |
0.97 |
chr16_56703511_56703662 | 0.79 |
MT1H |
metallothionein 1H |
140 |
0.88 |
chr2_200322305_200322456 | 0.79 |
SATB2-AS1 |
SATB2 antisense RNA 1 |
43 |
0.88 |
chr3_134369794_134369945 | 0.79 |
KY |
kyphoscoliosis peptidase |
5 |
0.98 |
chr3_184286763_184286975 | 0.79 |
EPHB3 |
EPH receptor B3 |
7297 |
0.2 |
chr11_61595650_61595801 | 0.79 |
FADS2 |
fatty acid desaturase 2 |
27 |
0.94 |
chr22_20286657_20286829 | 0.79 |
XXbac-B444P24.13 |
|
19529 |
0.11 |
chr6_166755718_166755869 | 0.79 |
SFT2D1 |
SFT2 domain containing 1 |
286 |
0.91 |
chr19_50432510_50432661 | 0.78 |
NUP62 |
nucleoporin 62kDa |
101 |
0.37 |
chr6_43739183_43739466 | 0.78 |
VEGFA |
vascular endothelial growth factor A |
340 |
0.78 |
chr11_101981093_101981244 | 0.78 |
YAP1 |
Yes-associated protein 1 |
24 |
0.97 |
chr4_15004584_15004759 | 0.78 |
CPEB2 |
cytoplasmic polyadenylation element binding protein 2 |
373 |
0.92 |
chr12_7023886_7024037 | 0.78 |
ENO2 |
enolase 2 (gamma, neuronal) |
187 |
0.83 |
chr1_154297413_154297726 | 0.78 |
ATP8B2 |
ATPase, aminophospholipid transporter, class I, type 8B, member 2 |
460 |
0.66 |
chr12_6876238_6876445 | 0.78 |
MLF2 |
myeloid leukemia factor 2 |
300 |
0.67 |
chr17_17685761_17685912 | 0.78 |
RAI1 |
retinoic acid induced 1 |
390 |
0.76 |
chr11_75294844_75295036 | 0.78 |
CTD-2530H12.4 |
|
699 |
0.6 |
chr18_43913575_43913778 | 0.78 |
RNF165 |
ring finger protein 165 |
255 |
0.95 |
chr4_141490140_141490356 | 0.77 |
UCP1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
289 |
0.9 |
chr17_72889150_72889301 | 0.77 |
FADS6 |
fatty acid desaturase 6 |
483 |
0.68 |
chr22_37691298_37691449 | 0.77 |
CYTH4 |
cytohesin 4 |
12845 |
0.16 |
chr11_2165632_2165909 | 0.77 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
3302 |
0.13 |
chr1_29450884_29451169 | 0.77 |
TMEM200B |
transmembrane protein 200B |
579 |
0.76 |
chr6_149069257_149069416 | 0.77 |
UST |
uronyl-2-sulfotransferase |
872 |
0.75 |
chr16_30935010_30935161 | 0.76 |
FBXL19 |
F-box and leucine-rich repeat protein 19 |
333 |
0.54 |
chr11_46411222_46411475 | 0.76 |
CHRM4 |
cholinergic receptor, muscarinic 4 |
3241 |
0.17 |
chr13_44361106_44361257 | 0.76 |
ENOX1 |
ecto-NOX disulfide-thiol exchanger 1 |
137 |
0.98 |
chr4_53728410_53728561 | 0.76 |
RASL11B |
RAS-like, family 11, member B |
28 |
0.98 |
chr4_109090119_109090270 | 0.76 |
LEF1 |
lymphoid enhancer-binding factor 1 |
82 |
0.97 |
chr17_35293439_35293727 | 0.76 |
RP11-445F12.1 |
|
338 |
0.59 |
chr8_127567681_127568033 | 0.75 |
RP11-103H7.5 |
|
1284 |
0.38 |
chr19_45943293_45943470 | 0.75 |
ERCC1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
10602 |
0.11 |
chr2_12857216_12857660 | 0.75 |
TRIB2 |
tribbles pseudokinase 2 |
377 |
0.91 |
chr12_3068801_3068977 | 0.75 |
TEAD4 |
TEA domain family member 4 |
73 |
0.96 |
chr4_76555942_76556093 | 0.75 |
CDKL2 |
cyclin-dependent kinase-like 2 (CDC2-related kinase) |
117 |
0.96 |
chr14_70038682_70038904 | 0.75 |
CCDC177 |
coiled-coil domain containing 177 |
761 |
0.71 |
chr2_27071459_27071610 | 0.75 |
DPYSL5 |
dihydropyrimidinase-like 5 |
158 |
0.96 |
chr7_556973_557124 | 0.75 |
PDGFA |
platelet-derived growth factor alpha polypeptide |
1097 |
0.53 |
chr6_132272068_132272363 | 0.74 |
RP11-69I8.3 |
|
129 |
0.72 |
chr17_79360953_79361175 | 0.74 |
RP11-1055B8.6 |
Uncharacterized protein |
8211 |
0.12 |
chr1_201857914_201858127 | 0.74 |
SHISA4 |
shisa family member 4 |
184 |
0.91 |
chr1_9242350_9242501 | 0.74 |
ENSG00000207865 |
. |
30589 |
0.15 |
chr8_128750160_128750448 | 0.74 |
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
1827 |
0.46 |
chr20_62338553_62338786 | 0.73 |
ZGPAT |
zinc finger, CCCH-type with G patch domain |
148 |
0.7 |
chr1_1004228_1004379 | 0.73 |
RNF223 |
ring finger protein 223 |
5384 |
0.1 |
chr1_244212933_244213084 | 0.73 |
ZBTB18 |
zinc finger and BTB domain containing 18 |
1577 |
0.43 |
chr7_138720207_138720441 | 0.73 |
ZC3HAV1L |
zinc finger CCCH-type, antiviral 1-like |
451 |
0.85 |
chr9_4297910_4298061 | 0.73 |
GLIS3 |
GLIS family zinc finger 3 |
511 |
0.74 |
chr2_177502756_177502963 | 0.73 |
ENSG00000252027 |
. |
26545 |
0.25 |
chr2_96192443_96192594 | 0.73 |
AC009237.8 |
|
1425 |
0.53 |
chr6_106808558_106808709 | 0.73 |
RP11-404H14.1 |
|
1041 |
0.52 |
chr19_872029_872211 | 0.73 |
CFD |
complement factor D (adipsin) |
12430 |
0.07 |
chr14_65879973_65880261 | 0.73 |
FUT8 |
fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
377 |
0.9 |
chr16_1822722_1822873 | 0.73 |
MRPS34 |
mitochondrial ribosomal protein S34 |
354 |
0.43 |
chr5_322140_322309 | 0.72 |
AHRR |
aryl-hydrocarbon receptor repressor |
350 |
0.87 |
chr1_55007626_55007867 | 0.72 |
ACOT11 |
acyl-CoA thioesterase 11 |
6155 |
0.18 |
chr11_101980776_101980970 | 0.72 |
YAP1 |
Yes-associated protein 1 |
319 |
0.86 |
chr2_227663405_227663664 | 0.72 |
IRS1 |
insulin receptor substrate 1 |
941 |
0.59 |
chr2_175207067_175207382 | 0.72 |
AC018470.1 |
Uncharacterized protein FLJ46347 |
5073 |
0.18 |
chr15_79103395_79103591 | 0.72 |
ADAMTS7 |
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
280 |
0.76 |
chr10_61645622_61645773 | 0.72 |
CCDC6 |
coiled-coil domain containing 6 |
20717 |
0.24 |
chr4_142558013_142558295 | 0.72 |
IL15 |
interleukin 15 |
54 |
0.99 |
chr20_30555661_30555845 | 0.72 |
XKR7 |
XK, Kell blood group complex subunit-related family, member 7 |
52 |
0.96 |
chr2_740601_740858 | 0.72 |
AC092159.3 |
|
47494 |
0.15 |
chr6_83073756_83074156 | 0.71 |
TPBG |
trophoblast glycoprotein |
5 |
0.99 |
chr1_220921776_220921927 | 0.71 |
MARC2 |
mitochondrial amidoxime reducing component 2 |
175 |
0.95 |
chr22_41843929_41844303 | 0.71 |
TOB2 |
transducer of ERBB2, 2 |
1089 |
0.43 |
chr2_232526773_232526924 | 0.71 |
ENSG00000239202 |
. |
15864 |
0.16 |
chr19_1104140_1104299 | 0.71 |
GPX4 |
glutathione peroxidase 4 |
147 |
0.92 |
chr20_62461832_62461983 | 0.71 |
ZBTB46 |
zinc finger and BTB domain containing 46 |
660 |
0.5 |
chr7_42277184_42277379 | 0.71 |
GLI3 |
GLI family zinc finger 3 |
623 |
0.85 |
chr3_167813473_167813624 | 0.71 |
GOLIM4 |
golgi integral membrane protein 4 |
215 |
0.97 |
chr1_212872826_212872977 | 0.71 |
BATF3 |
basic leucine zipper transcription factor, ATF-like 3 |
426 |
0.82 |
chr11_10952893_10953186 | 0.71 |
ZBED5-AS1 |
ZBED5 antisense RNA 1 |
66231 |
0.1 |
chr13_24153750_24153949 | 0.71 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
330 |
0.93 |
chr3_50404117_50404268 | 0.70 |
XXcos-LUCA11.4 |
|
538 |
0.54 |
chr10_99259233_99259384 | 0.70 |
UBTD1 |
ubiquitin domain containing 1 |
683 |
0.4 |
chr15_37393541_37393790 | 0.70 |
MEIS2 |
Meis homeobox 2 |
161 |
0.95 |
chr12_122017058_122017209 | 0.70 |
KDM2B |
lysine (K)-specific demethylase 2B |
416 |
0.85 |
chr8_145005057_145005290 | 0.70 |
PLEC |
plectin |
3994 |
0.13 |
chr1_77748105_77748256 | 0.70 |
AK5 |
adenylate kinase 5 |
107 |
0.98 |
chr10_102882852_102883003 | 0.70 |
HUG1 |
|
391 |
0.78 |
chr17_37782848_37782999 | 0.70 |
PPP1R1B |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
70 |
0.95 |
chr2_65658777_65658974 | 0.70 |
SPRED2 |
sprouty-related, EVH1 domain containing 2 |
436 |
0.88 |
chr12_64237996_64238246 | 0.70 |
SRGAP1 |
SLIT-ROBO Rho GTPase activating protein 1 |
48 |
0.97 |
chr19_10400822_10400973 | 0.69 |
ICAM5 |
intercellular adhesion molecule 5, telencephalin |
240 |
0.76 |
chrX_40005359_40005510 | 0.69 |
BCOR |
BCL6 corepressor |
448 |
0.9 |
chr14_105944529_105944680 | 0.69 |
CRIP2 |
cysteine-rich protein 2 |
3449 |
0.13 |
chr3_194354391_194354771 | 0.69 |
TMEM44 |
transmembrane protein 44 |
163 |
0.88 |
chr4_2464466_2464617 | 0.69 |
RNF4 |
ring finger protein 4 |
594 |
0.57 |
chr17_1928690_1928841 | 0.69 |
RTN4RL1 |
reticulon 4 receptor-like 1 |
126 |
0.9 |
chr10_134259846_134259997 | 0.69 |
C10orf91 |
chromosome 10 open reading frame 91 |
1228 |
0.45 |
chr17_76531085_76531470 | 0.69 |
ENSG00000243426 |
. |
2140 |
0.28 |
chr17_76349272_76349423 | 0.69 |
SOCS3 |
suppressor of cytokine signaling 3 |
6808 |
0.15 |
chr3_120169654_120169805 | 0.69 |
FSTL1 |
follistatin-like 1 |
109 |
0.98 |
chr19_51228108_51228259 | 0.69 |
CLEC11A |
C-type lectin domain family 11, member A |
1403 |
0.27 |
chr10_104159031_104159182 | 0.69 |
NFKB2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
3643 |
0.14 |
chr17_27347014_27347205 | 0.69 |
AC024619.2 |
|
4749 |
0.12 |
chr17_8534051_8534202 | 0.69 |
MYH10 |
myosin, heavy chain 10, non-muscle |
47 |
0.98 |
chr7_158622639_158622790 | 0.69 |
ESYT2 |
extended synaptotagmin-like protein 2 |
395 |
0.89 |
chr17_31254814_31254990 | 0.69 |
TMEM98 |
transmembrane protein 98 |
26 |
0.98 |
chr19_42463079_42463289 | 0.68 |
RABAC1 |
Rab acceptor 1 (prenylated) |
118 |
0.95 |
chr16_4743908_4744059 | 0.68 |
NUDT16L1 |
nudix (nucleoside diphosphate linked moiety X)-type motif 16-like 1 |
221 |
0.89 |
chr12_133135436_133135688 | 0.68 |
P2RX2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
59804 |
0.1 |
chr9_140205856_140206007 | 0.68 |
NRARP |
NOTCH-regulated ankyrin repeat protein |
9228 |
0.1 |
chr5_34656752_34656903 | 0.68 |
RAI14 |
retinoic acid induced 14 |
123 |
0.87 |
chr11_69458017_69458168 | 0.68 |
CCND1 |
cyclin D1 |
2118 |
0.35 |
chr6_41610672_41610823 | 0.68 |
MDFI |
MyoD family inhibitor |
4482 |
0.18 |
chr2_54684015_54684166 | 0.68 |
SPTBN1 |
spectrin, beta, non-erythrocytic 1 |
308 |
0.93 |
chr18_46066416_46066672 | 0.68 |
CTIF |
CBP80/20-dependent translation initiation factor |
78 |
0.98 |
chr12_3602627_3602778 | 0.68 |
PRMT8 |
protein arginine methyltransferase 8 |
2300 |
0.37 |
chr21_27542570_27542931 | 0.68 |
APP |
amyloid beta (A4) precursor protein |
222 |
0.94 |
chr4_7043959_7044306 | 0.68 |
TADA2B |
transcriptional adaptor 2B |
506 |
0.46 |
chr10_102891643_102891794 | 0.67 |
TLX1 |
T-cell leukemia homeobox 1 |
657 |
0.44 |
chr16_85588898_85589049 | 0.67 |
GSE1 |
Gse1 coiled-coil protein |
56042 |
0.12 |
chr8_22023106_22023363 | 0.67 |
BMP1 |
bone morphogenetic protein 1 |
434 |
0.71 |
chr5_102091361_102091713 | 0.67 |
PAM |
peptidylglycine alpha-amidating monooxygenase |
490 |
0.89 |
chr15_31557369_31557520 | 0.67 |
KLF13 |
Kruppel-like factor 13 |
61614 |
0.14 |
chr2_219762742_219762992 | 0.67 |
WNT10A |
wingless-type MMTV integration site family, member 10A |
15984 |
0.1 |
chr7_155249926_155250111 | 0.67 |
EN2 |
engrailed homeobox 2 |
806 |
0.65 |
chr1_28586799_28587133 | 0.67 |
SESN2 |
sestrin 2 |
928 |
0.45 |
chr11_35160511_35160662 | 0.67 |
CD44 |
CD44 molecule (Indian blood group) |
131 |
0.92 |
chr11_66623958_66624188 | 0.67 |
LRFN4 |
leucine rich repeat and fibronectin type III domain containing 4 |
516 |
0.7 |
chr7_143079009_143079384 | 0.67 |
ZYX |
zyxin |
196 |
0.88 |
chr5_141736312_141736463 | 0.66 |
AC005592.2 |
|
3279 |
0.31 |
chr1_201617506_201617657 | 0.66 |
NAV1 |
neuron navigator 1 |
131 |
0.95 |
chr1_2347463_2347709 | 0.66 |
PEX10 |
peroxisomal biogenesis factor 10 |
2350 |
0.17 |
chr7_2393665_2393816 | 0.66 |
EIF3B |
eukaryotic translation initiation factor 3, subunit B |
19 |
0.73 |
chr2_219866694_219866845 | 0.66 |
AC097468.4 |
|
168 |
0.67 |
chr9_132427553_132427874 | 0.66 |
PRRX2 |
paired related homeobox 2 |
207 |
0.91 |
chr19_39898529_39898680 | 0.66 |
ZFP36 |
ZFP36 ring finger protein |
525 |
0.53 |
chr1_234350399_234350630 | 0.66 |
RP4-799P18.2 |
|
320 |
0.63 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.0 | 4.0 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.8 | 2.3 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.7 | 2.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.7 | 0.7 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.7 | 3.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.7 | 0.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.7 | 4.0 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.7 | 2.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.6 | 2.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.6 | 1.9 | GO:0001705 | ectoderm formation(GO:0001705) |
0.6 | 1.8 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.5 | 1.6 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.5 | 1.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.5 | 1.6 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.5 | 0.5 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.5 | 1.5 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.5 | 1.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.5 | 1.0 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.5 | 1.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.5 | 1.5 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.5 | 2.4 | GO:0002063 | chondrocyte development(GO:0002063) |
0.5 | 1.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.5 | 1.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 5.6 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.5 | 0.5 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.5 | 1.4 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.4 | 0.4 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.4 | 1.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.4 | 1.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.4 | 2.2 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.4 | 0.9 | GO:0072182 | nephron tubule epithelial cell differentiation(GO:0072160) regulation of nephron tubule epithelial cell differentiation(GO:0072182) regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.4 | 1.7 | GO:0002604 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) |
0.4 | 0.8 | GO:0015809 | arginine transport(GO:0015809) |
0.4 | 2.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.4 | 1.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 1.7 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.4 | 2.5 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.4 | 0.8 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.4 | 1.6 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.4 | 1.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.4 | 0.4 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.4 | 1.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.4 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.4 | 0.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.4 | 1.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 0.4 | GO:0031529 | ruffle organization(GO:0031529) |
0.4 | 1.6 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.4 | 1.2 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.4 | 0.8 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 0.4 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.4 | 1.5 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.4 | 1.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.4 | 1.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.4 | 0.4 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.4 | 0.7 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.4 | 0.7 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.4 | 0.7 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.4 | 0.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.4 | 2.9 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.4 | 0.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 1.1 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.4 | 0.7 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.4 | 1.4 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.4 | 1.4 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.4 | 1.4 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.4 | 0.4 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.4 | 1.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.4 | 1.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.4 | 1.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.3 | 1.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 1.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 0.3 | GO:0046449 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.3 | 1.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 1.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.3 | 0.3 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.3 | 1.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.3 | 2.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 1.0 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 1.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 1.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.3 | 1.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.3 | 0.3 | GO:2000316 | T-helper cell lineage commitment(GO:0002295) alpha-beta T cell lineage commitment(GO:0002363) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) T-helper 17 cell lineage commitment(GO:0072540) regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 17 cell differentiation(GO:2000319) positive regulation of T-helper 17 cell differentiation(GO:2000321) regulation of T-helper 17 cell lineage commitment(GO:2000328) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.3 | 1.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.3 | 0.6 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.3 | 1.9 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 1.0 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.3 | 0.6 | GO:0032825 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.3 | 0.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 3.1 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.3 | 2.5 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 0.9 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.3 | 0.9 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 1.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 0.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 0.3 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.3 | 0.9 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.3 | 1.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 1.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 0.6 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.3 | 2.1 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.3 | 0.9 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 1.5 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.3 | 1.5 | GO:0046645 | regulation of gamma-delta T cell differentiation(GO:0045586) positive regulation of gamma-delta T cell differentiation(GO:0045588) regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.3 | 1.2 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.3 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 1.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 0.9 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 1.2 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.3 | 1.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 0.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 0.9 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.9 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 0.3 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.3 | 0.9 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.3 | 0.9 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 0.3 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.3 | 0.9 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.3 | 0.3 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.3 | 0.6 | GO:0071436 | sodium ion export(GO:0071436) |
0.3 | 2.2 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.3 | 0.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.3 | 0.8 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.3 | 0.6 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.3 | 0.6 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.3 | 1.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.5 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.3 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 1.4 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.3 | 0.5 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.3 | 0.3 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 0.5 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.3 | 0.8 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.3 | 0.8 | GO:0071501 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 0.3 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.3 | 0.5 | GO:0032747 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 2.1 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.3 | 0.5 | GO:0060596 | mammary placode formation(GO:0060596) |
0.3 | 0.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 0.3 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.3 | 1.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 0.8 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.3 | 0.5 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.3 | 2.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.3 | 2.1 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.3 | 0.8 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 0.5 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.3 | 0.8 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.3 | 0.8 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.3 | 0.3 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.3 | 1.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 1.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.3 | 0.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.3 | 0.3 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.3 | 0.8 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.3 | 0.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.3 | 0.3 | GO:0071173 | spindle assembly checkpoint(GO:0071173) |
0.3 | 0.8 | GO:0015816 | glycine transport(GO:0015816) |
0.3 | 0.5 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 1.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 0.5 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.5 | GO:0097035 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) regulation of membrane lipid distribution(GO:0097035) |
0.2 | 0.5 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 1.7 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 0.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 1.2 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.2 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 1.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.2 | 1.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.5 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.2 | 1.5 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.2 | 0.2 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.2 | 0.7 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 1.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.7 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.2 | 1.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.2 | 1.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.7 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.9 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.7 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.2 | 0.2 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 0.5 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
0.2 | 2.3 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.2 | 2.3 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.2 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.9 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 1.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.2 | 0.2 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.2 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.7 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 0.2 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.2 | 0.7 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.2 | 0.5 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 0.4 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.2 | 0.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.7 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.2 | 0.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.9 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.2 | 0.9 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.2 | 0.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 2.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 1.5 | GO:0006560 | proline metabolic process(GO:0006560) |
0.2 | 1.5 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 0.2 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.2 | 0.4 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.2 | 1.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 1.1 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.2 | 0.6 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.6 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.2 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.2 | 0.8 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.6 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 1.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.2 | 0.8 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 0.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 0.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.8 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 1.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.2 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 2.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 1.0 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.2 | 1.4 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 0.2 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.2 | 0.6 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.2 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.2 | 1.8 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 3.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.2 | 1.8 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.2 | 1.4 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.2 | 0.4 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.2 | 0.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 1.8 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.2 | 0.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 0.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.2 | 1.0 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.6 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 1.4 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.2 | 1.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 2.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.4 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 0.4 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.2 | 0.4 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.2 | 0.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 1.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.4 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 0.6 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.2 | 0.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 0.6 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.2 | 1.5 | GO:0051322 | anaphase(GO:0051322) |
0.2 | 0.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.7 | GO:0046618 | drug export(GO:0046618) |
0.2 | 0.6 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.2 | 0.7 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.2 | 1.3 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.2 | 0.7 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 1.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 0.6 | GO:2000351 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.2 | 0.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.4 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.2 | 0.5 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.2 | 0.4 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.2 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 1.8 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 1.3 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.2 | 0.4 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.2 | 0.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 1.5 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 0.7 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.2 | 1.1 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.2 | 0.9 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 0.4 | GO:2000757 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 0.5 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 4.3 | GO:1903363 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) negative regulation of cellular protein catabolic process(GO:1903363) |
0.2 | 0.5 | GO:0060174 | limb bud formation(GO:0060174) |
0.2 | 0.4 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.7 | GO:0001820 | serotonin secretion(GO:0001820) |
0.2 | 1.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.7 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.7 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 1.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.7 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 0.7 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 0.3 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.2 | 0.5 | GO:0071694 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.2 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.2 | 0.5 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.2 | 1.0 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.2 | 0.9 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.2 | 0.7 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.2 | 0.2 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.2 | 0.7 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.2 | 0.9 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 1.4 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 1.0 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.2 | 0.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.2 | GO:0090201 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.2 | 2.2 | GO:0016575 | histone deacetylation(GO:0016575) |
0.2 | 0.2 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.2 | 0.2 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.2 | 2.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.3 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.2 | 0.7 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.2 | 0.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 3.3 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.2 | 0.8 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.8 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.2 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.3 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.2 | 0.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.2 | 0.5 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.2 | 0.7 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.2 | 1.0 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.2 | 0.7 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.3 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.2 | 0.5 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.2 | 0.6 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.5 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 1.0 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 1.0 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 0.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.6 | GO:0031641 | regulation of myelination(GO:0031641) |
0.2 | 0.5 | GO:0035930 | corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.2 | 0.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 0.5 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.2 | 0.2 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.2 | 0.2 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 0.6 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.2 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 1.3 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.2 | 0.2 | GO:0045684 | positive regulation of epidermis development(GO:0045684) |
0.2 | 3.0 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.2 | 0.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.3 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 1.2 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
0.2 | 0.6 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.2 | 0.3 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.2 | 0.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.6 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.2 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.5 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.2 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle organ development(GO:0048635) negative regulation of muscle tissue development(GO:1901862) |
0.2 | 1.7 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.2 | 1.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 1.8 | GO:0060606 | primary neural tube formation(GO:0014020) tube closure(GO:0060606) |
0.2 | 1.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.2 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.2 | 2.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.2 | 0.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.2 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.3 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.2 | 0.5 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 0.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.2 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.2 | 1.4 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 1.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 0.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.6 | GO:0030878 | thyroid gland development(GO:0030878) |
0.2 | 0.2 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.2 | 0.8 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 1.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.6 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.6 | GO:0032727 | interferon-alpha production(GO:0032607) regulation of interferon-alpha production(GO:0032647) positive regulation of interferon-alpha production(GO:0032727) |
0.1 | 0.1 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.1 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.1 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 0.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 1.0 | GO:0046051 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.1 | 0.4 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 1.2 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 1.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.4 | GO:0097502 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.1 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.3 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.1 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.3 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.1 | 0.4 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.1 | 1.0 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 1.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.4 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.3 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.4 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.1 | 0.4 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.1 | 1.1 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 1.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.1 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 3.2 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.8 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 1.0 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.5 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.5 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 1.1 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.4 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.1 | GO:0051348 | negative regulation of transferase activity(GO:0051348) |
0.1 | 0.1 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.4 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.1 | 1.2 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.1 | 0.7 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.4 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.5 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.1 | 0.5 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.8 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.1 | 0.3 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.1 | 1.5 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.8 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.3 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.1 | 0.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.1 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.4 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.1 | GO:0061043 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.1 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.8 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 0.3 | GO:0035307 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.1 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.3 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 0.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.2 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.1 | 5.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.1 | GO:0098900 | regulation of action potential(GO:0098900) |
0.1 | 0.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.9 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 1.6 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.4 | GO:0010714 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.2 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 2.4 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.6 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.1 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 2.5 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.1 | 0.5 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.4 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 1.4 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.1 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.1 | 1.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.4 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.6 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 2.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.7 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.1 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.1 | 0.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.1 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.1 | 0.3 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.3 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.2 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.2 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.1 | GO:0001743 | optic placode formation(GO:0001743) |
0.1 | 0.2 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.8 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 1.0 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 6.3 | GO:0009201 | ribonucleoside triphosphate biosynthetic process(GO:0009201) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
0.1 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.6 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.1 | 0.4 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.1 | 0.4 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 1.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.1 | GO:0021610 | rhombomere 4 development(GO:0021570) cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) |
0.1 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.6 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.5 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
0.1 | 0.1 | GO:0002517 | NK T cell differentiation(GO:0001865) T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 1.6 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.4 | GO:0050868 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.1 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.3 | GO:0016139 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.1 | 0.5 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 1.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.1 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.3 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.1 | GO:0071514 | genetic imprinting(GO:0071514) |
0.1 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.1 | GO:0035510 | DNA dealkylation involved in DNA repair(GO:0006307) DNA dealkylation(GO:0035510) |
0.1 | 0.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.7 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 2.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.1 | GO:0021754 | facial nucleus development(GO:0021754) |
0.1 | 0.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.3 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.1 | 0.4 | GO:0032309 | icosanoid secretion(GO:0032309) |
0.1 | 0.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.4 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 0.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.3 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.1 | 0.4 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 1.6 | GO:1990266 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.1 | 0.4 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 2.9 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.1 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
0.1 | 1.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.2 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.3 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.3 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.3 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.1 | 0.6 | GO:0007567 | parturition(GO:0007567) |
0.1 | 1.5 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.1 | 0.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.6 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.3 | GO:1901796 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) regulation of signal transduction by p53 class mediator(GO:1901796) |
0.1 | 3.7 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.1 | 1.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.7 | GO:0010921 | regulation of phosphatase activity(GO:0010921) regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.3 | GO:0070875 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 0.3 | GO:0051329 | mitotic interphase(GO:0051329) |
0.1 | 0.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.8 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.1 | 0.2 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 1.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 9.9 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 3.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:0035967 | cellular response to topologically incorrect protein(GO:0035967) |
0.1 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.6 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 1.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 1.5 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 0.3 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 0.2 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 2.0 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.5 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.1 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 1.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.1 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.1 | 0.4 | GO:0006090 | pyruvate metabolic process(GO:0006090) |
0.1 | 0.2 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 1.2 | GO:0006026 | aminoglycan catabolic process(GO:0006026) glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 1.1 | GO:0009309 | amine biosynthetic process(GO:0009309) |
0.1 | 0.1 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 1.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.1 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.1 | 0.2 | GO:0001776 | leukocyte homeostasis(GO:0001776) |
0.1 | 0.6 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.1 | 0.3 | GO:0034311 | diol metabolic process(GO:0034311) |
0.1 | 0.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 1.3 | GO:0034968 | histone lysine methylation(GO:0034968) |
0.1 | 0.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 1.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 1.8 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.3 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.1 | 3.7 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.1 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.1 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.3 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.3 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.7 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 1.8 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.1 | 1.0 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.1 | GO:0021548 | pons development(GO:0021548) |
0.1 | 0.1 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.1 | 0.2 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.1 | 0.2 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.1 | 0.1 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 2.7 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.1 | 0.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.3 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.1 | 0.2 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.1 | 0.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.2 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
0.1 | 2.0 | GO:0071426 | ribonucleoprotein complex export from nucleus(GO:0071426) |
0.1 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.2 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 2.3 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.2 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 1.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 5.2 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.1 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.1 | 0.1 | GO:0052572 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.1 | 0.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 1.2 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.2 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.1 | 0.1 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.1 | 0.8 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.1 | 0.7 | GO:0097581 | lamellipodium organization(GO:0097581) |
0.1 | 3.5 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 1.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.8 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.2 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.2 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.1 | 0.2 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) cleavage involved in rRNA processing(GO:0000469) endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.4 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 0.1 | GO:0032623 | interleukin-2 production(GO:0032623) |
0.1 | 0.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 1.0 | GO:0051324 | prophase(GO:0051324) |
0.1 | 0.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.2 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.2 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.1 | 0.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 3.3 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.1 | 0.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.1 | GO:2000272 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) negative regulation of receptor activity(GO:2000272) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.2 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.1 | 0.4 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.1 | GO:0021694 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.2 | GO:0050856 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) regulation of T cell receptor signaling pathway(GO:0050856) |
0.1 | 3.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.8 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 1.2 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 0.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 6.6 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 1.3 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 1.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 1.2 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.1 | 0.3 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.3 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.2 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 1.0 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.3 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 1.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.4 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.3 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.2 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.1 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.1 | 1.2 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.1 | 0.9 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 2.5 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.1 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.1 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 0.1 | GO:0060479 | lung cell differentiation(GO:0060479) |
0.1 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.7 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.1 | 0.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 1.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.2 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 0.2 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.1 | 1.2 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 0.8 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) DNA methylation or demethylation(GO:0044728) |
0.1 | 0.2 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 0.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.8 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.1 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.1 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 0.3 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.1 | 6.9 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 0.1 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 0.6 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 1.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.2 | GO:0060033 | Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
0.1 | 0.4 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.2 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.3 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.2 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.1 | 0.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.2 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.1 | GO:0045851 | pH reduction(GO:0045851) |
0.1 | 0.5 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.2 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.2 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.1 | 0.2 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.5 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.1 | 1.0 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.2 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.1 | GO:0060996 | dendritic spine development(GO:0060996) |
0.1 | 0.4 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.2 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.1 | 0.1 | GO:0015853 | adenine transport(GO:0015853) |
0.1 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.1 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.1 | 0.6 | GO:0001889 | liver development(GO:0001889) |
0.1 | 0.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.3 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.6 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.1 | 0.7 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.4 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 4.2 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.7 | GO:0016311 | dephosphorylation(GO:0016311) |
0.1 | 0.3 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 1.1 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 2.0 | GO:0016197 | endosomal transport(GO:0016197) |
0.1 | 3.5 | GO:0000084 | mitotic S phase(GO:0000084) |
0.1 | 0.4 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.2 | GO:0007549 | dosage compensation(GO:0007549) |
0.1 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 2.1 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 0.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 1.2 | GO:0009135 | purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) |
0.1 | 0.1 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.1 | 0.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.1 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.1 | 0.1 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.2 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.3 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.1 | GO:0016571 | histone methylation(GO:0016571) |
0.1 | 0.2 | GO:0060004 | reflex(GO:0060004) |
0.0 | 0.1 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.0 | 0.3 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 3.3 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.0 | 0.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 1.1 | GO:0008652 | cellular amino acid biosynthetic process(GO:0008652) |
0.0 | 0.5 | GO:1903902 | positive regulation of viral process(GO:0048524) positive regulation of viral life cycle(GO:1903902) |
0.0 | 0.7 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.0 | 0.0 | GO:0033197 | response to vitamin E(GO:0033197) |
0.0 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 1.0 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 3.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.5 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.8 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.3 | GO:0031100 | organ regeneration(GO:0031100) |
0.0 | 0.0 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.0 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 0.0 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 2.1 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:0006304 | DNA modification(GO:0006304) |
0.0 | 0.1 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 1.1 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.0 | GO:0061387 | regulation of extent of cell growth(GO:0061387) |
0.0 | 0.6 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 4.0 | GO:0016032 | viral process(GO:0016032) |
0.0 | 0.1 | GO:0061136 | regulation of proteasomal protein catabolic process(GO:0061136) |
0.0 | 2.4 | GO:0034248 | regulation of cellular amide metabolic process(GO:0034248) |
0.0 | 0.0 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.0 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.2 | GO:0035601 | protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.5 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.0 | 0.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.4 | GO:0009582 | detection of abiotic stimulus(GO:0009582) |
0.0 | 0.2 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.0 | 0.4 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.4 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.0 | 0.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 4.3 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.0 | 0.1 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.0 | 0.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 4.6 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0007034 | vacuolar transport(GO:0007034) |
0.0 | 0.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.4 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
0.0 | 0.0 | GO:0051608 | histamine transport(GO:0051608) |
0.0 | 0.2 | GO:0050663 | cytokine secretion(GO:0050663) |
0.0 | 0.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.3 | GO:0009620 | response to fungus(GO:0009620) |
0.0 | 0.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.9 | GO:0016051 | carbohydrate biosynthetic process(GO:0016051) |
0.0 | 0.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.6 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.0 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.2 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 2.4 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.0 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.0 | 0.1 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.0 | GO:0055117 | regulation of cardiac muscle contraction(GO:0055117) |
0.0 | 0.1 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.0 | 0.1 | GO:0042816 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 7.1 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.0 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.5 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.0 | 0.8 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
0.0 | 0.0 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 0.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.3 | GO:0000279 | M phase(GO:0000279) |
0.0 | 0.9 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.4 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0051954 | positive regulation of amine transport(GO:0051954) |
0.0 | 0.1 | GO:0015748 | organophosphate ester transport(GO:0015748) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.0 | GO:0045924 | regulation of female receptivity(GO:0045924) female mating behavior(GO:0060180) |
0.0 | 0.0 | GO:0000272 | polysaccharide catabolic process(GO:0000272) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.3 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.0 | 0.0 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.0 | 0.1 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.0 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.1 | GO:0031638 | zymogen activation(GO:0031638) |
0.0 | 0.1 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
0.0 | 0.2 | GO:0006949 | syncytium formation by plasma membrane fusion(GO:0000768) syncytium formation(GO:0006949) myoblast fusion(GO:0007520) |
0.0 | 2.8 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.0 | 0.1 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.0 | 0.0 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.4 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.0 | 0.2 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.0 | GO:0034651 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.0 | 0.2 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.0 | 0.0 | GO:0015872 | dopamine transport(GO:0015872) |
0.0 | 0.2 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.0 | 0.2 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 3.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.2 | GO:0032259 | methylation(GO:0032259) |
0.0 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.0 | GO:0042158 | lipoprotein biosynthetic process(GO:0042158) |
0.0 | 0.0 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.7 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.0 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.0 | 0.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.1 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0001841 | neural tube formation(GO:0001841) |
0.0 | 0.4 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 2.4 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.1 | GO:0048645 | organ formation(GO:0048645) |
0.0 | 0.7 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.0 | 0.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.0 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.0 | 1.2 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.0 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.0 | 0.0 | GO:0007033 | vacuole organization(GO:0007033) |
0.0 | 0.4 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.1 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.0 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.0 | GO:0032392 | DNA geometric change(GO:0032392) DNA duplex unwinding(GO:0032508) |
0.0 | 0.1 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.0 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 0.2 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.0 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 1.8 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.0 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.1 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.0 | 0.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:1903305 | regulation of regulated secretory pathway(GO:1903305) |
0.0 | 0.5 | GO:0044839 | G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
0.0 | 0.0 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.0 | 0.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:0045047 | protein targeting to ER(GO:0045047) protein localization to endoplasmic reticulum(GO:0070972) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.0 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.0 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.0 | 2.4 | GO:0006325 | chromatin organization(GO:0006325) |
0.0 | 0.0 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.0 | 0.7 | GO:0034470 | ncRNA processing(GO:0034470) |
0.0 | 0.2 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.0 | 0.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.1 | GO:0042438 | melanin biosynthetic process(GO:0042438) secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.0 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.1 | GO:0031396 | regulation of protein ubiquitination(GO:0031396) |
0.0 | 1.2 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 1.0 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.3 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.0 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.0 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.3 | GO:0007623 | circadian rhythm(GO:0007623) |
0.0 | 0.2 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.0 | 0.1 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.0 | 0.3 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.0 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.2 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 0.1 | GO:0030819 | positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) |
0.0 | 0.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.9 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 1.0 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.0 | 0.0 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.3 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.0 | 0.2 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.0 | 0.6 | GO:0051346 | negative regulation of hydrolase activity(GO:0051346) |
0.0 | 0.4 | GO:0070085 | glycosylation(GO:0070085) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.0 | 0.1 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.0 | 0.0 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.2 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 0.0 | GO:0051904 | pigment granule transport(GO:0051904) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.5 | 2.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.5 | 1.5 | GO:0072487 | MSL complex(GO:0072487) |
0.5 | 1.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 1.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 0.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 1.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 0.3 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 0.9 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.3 | 1.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 1.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 0.9 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.3 | 1.7 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.3 | 1.1 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.3 | 1.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 3.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 1.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 0.3 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.3 | 1.1 | GO:0032059 | bleb(GO:0032059) |
0.3 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 0.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 2.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 1.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 4.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.7 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.2 | 2.4 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 3.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 1.4 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.2 | 1.6 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.2 | 4.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 1.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.2 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.2 | 0.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 1.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 1.7 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 1.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.4 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.6 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 1.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.7 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 1.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.6 | GO:0031904 | endosome lumen(GO:0031904) |
0.2 | 0.6 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 2.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 1.3 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 0.7 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.2 | 0.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 2.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 2.3 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 1.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 0.5 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.2 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.5 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 3.5 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 4.0 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 1.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 2.7 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.2 | 1.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 0.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.2 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.2 | 1.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 4.5 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.4 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 1.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.7 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 7.5 | GO:0030496 | midbody(GO:0030496) |
0.1 | 1.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 1.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 2.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 1.2 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 0.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 1.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 3.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 1.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 1.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 2.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.8 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.0 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.4 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.1 | 7.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 9.5 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 2.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 0.7 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.4 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 2.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.6 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 1.7 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.1 | 2.6 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 0.1 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 0.4 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 1.8 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 1.8 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 1.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.6 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.7 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 3.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 3.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 1.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.7 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 3.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.3 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 1.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 1.9 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 2.5 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 1.7 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.1 | 0.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 9.7 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 2.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 1.0 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 1.3 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 1.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 9.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 4.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 4.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 2.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.5 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.4 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.1 | 0.1 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.1 | 1.3 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.9 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 1.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 16.1 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 4.4 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.1 | 0.3 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 2.0 | GO:0030427 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
0.1 | 1.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 4.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 2.4 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 2.3 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.3 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 1.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 2.8 | GO:0016605 | PML body(GO:0016605) |
0.1 | 1.5 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 2.4 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 7.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 13.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 5.8 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.5 | GO:0031090 | organelle membrane(GO:0031090) |
0.1 | 1.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 2.5 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.4 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 3.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.9 | GO:0031252 | cell leading edge(GO:0031252) |
0.1 | 1.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 3.0 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.8 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 18.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 2.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 1.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 1.9 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 9.1 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.1 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 3.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 56.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 1.2 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 6.4 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.8 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.5 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.3 | GO:0032153 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.1 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.5 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 2.6 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.5 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 4.8 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.2 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 27.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 178.8 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 1.6 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.3 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 4.9 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.0 | GO:0043656 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.5 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 2.6 | GO:0012506 | vesicle membrane(GO:0012506) |
0.0 | 0.7 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.0 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 0.1 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.2 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.0 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.4 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.0 | 0.8 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 17.3 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.5 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.5 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.2 | GO:0072372 | primary cilium(GO:0072372) |
0.0 | 0.0 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.0 | GO:0002142 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.3 | GO:0016459 | myosin complex(GO:0016459) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 0.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.7 | 2.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.6 | 1.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.6 | 2.2 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.6 | 2.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 1.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.5 | 1.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.5 | 1.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 1.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 1.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.5 | 2.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.5 | 2.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 1.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.5 | 1.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 1.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.4 | 1.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.4 | 1.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.4 | 1.7 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.4 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 1.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 1.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.4 | 1.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 1.2 | GO:0019863 | IgE binding(GO:0019863) |
0.4 | 4.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 2.5 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.4 | 1.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.4 | 1.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.3 | 1.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.3 | 3.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 3.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 1.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 1.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 1.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 0.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 1.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 3.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 2.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.3 | 1.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 3.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.3 | 1.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 1.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 0.9 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 2.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 1.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 1.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 1.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 0.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 1.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 0.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 2.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 1.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 1.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 1.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 1.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 1.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 0.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 1.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 1.4 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.3 | 0.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.3 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.6 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 1.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.3 | 1.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 1.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.3 | 1.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 0.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.3 | 2.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.3 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 1.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 2.9 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.3 | 1.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 1.3 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.3 | 1.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 0.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 1.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 1.5 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 1.7 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.2 | 0.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 1.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 1.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.7 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 1.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 2.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.7 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 1.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 1.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 1.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 1.6 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 1.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 1.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 1.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.7 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.7 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.2 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.2 | 0.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 0.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.5 | GO:0005035 | death receptor activity(GO:0005035) |
0.2 | 2.0 | GO:0051117 | ATPase binding(GO:0051117) |
0.2 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 2.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 0.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.2 | 0.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 0.7 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 3.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.6 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 1.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 1.3 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.2 | 0.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 1.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.2 | 1.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 0.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 0.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 1.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 1.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 0.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 1.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.6 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.2 | 4.4 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.2 | 1.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 2.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 0.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 1.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 1.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 1.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 1.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 1.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 1.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 1.0 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 1.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 0.6 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.2 | 4.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 0.7 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 0.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 0.6 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 1.6 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.2 | 0.7 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.2 | 0.5 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.7 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 6.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 0.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 0.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 1.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 0.5 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.7 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 0.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 0.5 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.2 | 0.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.2 | 0.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 1.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 1.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.7 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 1.8 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 1.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 1.2 | GO:0070717 | poly(A) binding(GO:0008143) poly-purine tract binding(GO:0070717) |
0.2 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 2.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 0.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.2 | 1.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 1.8 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.2 | 7.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.8 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.6 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.2 | 1.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 1.0 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.2 | 4.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.2 | 1.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 0.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 1.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 0.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.2 | 0.5 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.2 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.2 | 0.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 0.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.4 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.2 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 1.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 1.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 0.2 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 1.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.2 | 0.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 1.9 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 1.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 2.1 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.1 | GO:0044212 | regulatory region DNA binding(GO:0000975) regulatory region nucleic acid binding(GO:0001067) transcription regulatory region DNA binding(GO:0044212) |
0.1 | 2.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 5.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 1.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 1.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.4 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.7 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.4 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.1 | 7.1 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.4 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 0.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.5 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.8 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 1.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 1.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.7 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.1 | 3.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.7 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 1.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 4.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.3 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.1 | 0.5 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.1 | 0.5 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.1 | 1.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 4.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 1.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 1.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.5 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.1 | 1.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 2.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 1.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 3.1 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 1.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 1.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 1.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.5 | GO:0004340 | glucokinase activity(GO:0004340) |
0.1 | 0.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 1.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.4 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.1 | 0.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 4.2 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 8.5 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 0.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.7 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 1.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.5 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) ether hydrolase activity(GO:0016803) |
0.1 | 0.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 1.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.0 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.3 | GO:0046970 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.1 | 0.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.2 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 1.0 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.6 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.3 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 1.1 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.1 | 0.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 0.4 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.1 | 1.8 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.6 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.1 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 2.5 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.5 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 2.0 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.2 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 2.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.3 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 1.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.7 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 2.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 1.9 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.3 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.1 | 0.8 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.3 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 1.6 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.3 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.1 | 1.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.4 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.6 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 1.9 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 4.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 3.8 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.9 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.1 | 3.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 1.3 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 1.0 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.5 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 2.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 9.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 2.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 1.9 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 3.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 1.1 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.3 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.6 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 1.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.8 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.1 | 0.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 6.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.4 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 2.7 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.9 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 12.9 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 6.0 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.1 | 0.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.8 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 1.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 1.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 2.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.2 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.5 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.1 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.1 | 1.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 2.3 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 1.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 1.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.3 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 1.4 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 3.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.2 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 0.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 2.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 1.2 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 0.5 | GO:0016248 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
0.1 | 0.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.3 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 5.4 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 1.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.7 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.9 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 1.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 2.3 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.5 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 0.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.3 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.5 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 0.8 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 2.0 | GO:0010843 | obsolete promoter binding(GO:0010843) |
0.1 | 0.2 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 2.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 1.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.9 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.3 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.4 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.7 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.1 | 0.6 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.1 | 0.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 77.8 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.2 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.1 | 0.1 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.1 | 1.9 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 1.5 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 0.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.7 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 1.2 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 0.1 | GO:0016411 | 2-acylglycerol O-acyltransferase activity(GO:0003846) acylglycerol O-acyltransferase activity(GO:0016411) |
0.1 | 0.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.2 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.5 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.5 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.0 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 1.3 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 8.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 16.0 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 1.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0051192 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.0 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.2 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.2 | GO:1990837 | sequence-specific double-stranded DNA binding(GO:1990837) |
0.0 | 0.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 8.0 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 0.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 9.3 | GO:0032561 | GTP binding(GO:0005525) guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.0 | 0.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 2.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 1.5 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.3 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.5 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.0 | 1.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.2 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.3 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.0 | 0.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.6 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 1.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.6 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.5 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 4.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.0 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.0 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.1 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 1.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 2.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 1.7 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 3.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.9 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.5 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 1.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.0 | 0.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.7 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.0 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 1.0 | GO:0019900 | kinase binding(GO:0019900) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.0 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.0 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.0 | 0.0 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.0 | 0.4 | GO:0042623 | ATPase activity, coupled(GO:0042623) |
0.0 | 0.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.0 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.0 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 3.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.4 | 0.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 2.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 0.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 3.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 7.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 7.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 14.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 8.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 3.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 1.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 6.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 3.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 1.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 4.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 1.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 5.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 1.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 6.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 1.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 2.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 4.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 2.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 3.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 2.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 2.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 2.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 1.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 4.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 1.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 1.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 3.0 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 5.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 1.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 3.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 4.7 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 5.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 5.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 4.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 4.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 3.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 6.9 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 2.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 2.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 2.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 2.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 3.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 3.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 2.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 1.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 2.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.7 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 3.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.7 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.7 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.9 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 1.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.0 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.6 | 0.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 1.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 4.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 3.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 5.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 3.5 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 1.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 7.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 0.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 2.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 5.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.3 | 7.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 3.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 0.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.3 | 1.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 5.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 7.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 4.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 3.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 0.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 2.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 1.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 1.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 0.9 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.2 | 1.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 0.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 3.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 4.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 4.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 0.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 1.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 1.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 5.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 3.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 1.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 3.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 1.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 5.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 0.2 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.2 | 3.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 3.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 3.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 0.4 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.2 | 2.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 1.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 2.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 3.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 3.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.2 | 2.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 1.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 1.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 0.3 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 0.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 1.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 1.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 0.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 2.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.1 | 0.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 1.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 2.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 2.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 1.9 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 2.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 1.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 3.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.0 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 1.9 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 3.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.9 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 2.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.1 | 7.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 3.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 2.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 3.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 5.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 4.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.4 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 0.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 2.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 19.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.8 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 4.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 3.5 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 0.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.5 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 5.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 3.1 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 0.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 4.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.1 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.2 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 0.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 1.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 3.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 1.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 5.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 1.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 1.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 5.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 1.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 1.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 1.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.8 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.7 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.2 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 1.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.1 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.0 | 1.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.8 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.3 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.0 | 1.2 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.2 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.0 | 0.2 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.0 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.2 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.0 | 0.6 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |